Mass General Brigham Innovation Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
31
- Investments
-
47
- Portfolio
-
6
- Exits
-
33
Mass General Brigham Innovation General Information
Company Description
Mass General Brigham Innovation is a corporate venture arm of Mass General Brigham based in Cambridge, Massachusetts. The firm seeks to invest in the healthcare sector.
Business Details
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 215 First Street
- Suite 500
- Cambridge, MA 02141
- United States
Mass General Brigham Innovation Investments & Acquisitions (47)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Verve Therapeutics | 14-Jan-2021 | Early Stage VC | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
Abcuro | 07-Jan-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 000000 00000 |
Scorpion Therapeutics | 26-Oct-2020 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
Quartet Health | 08-May-2019 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Generating Revenue | |
Syntimmune | 21-Jun-2017 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
Tarveda Therapeutics | 01-Dec-2016 | 00000 00000 | 000.00 | Drug Discovery | Bankruptcy: Liquidation | |
Daktari Diagnostics | 24-May-2016 | 00000 00000 | 000.00 | Diagnostic Equipment | Out of Business | 00000 000000 |
Cytrellis | 27-Apr-2016 | 00000 00000 | 000 | Other Devices and Supplies | Generating Revenue | |
ImmuneXcite | 30-Mar-2016 | Later Stage VC | 00.00 | Biotechnology | Out of Business | |
Health Catalyst | 18-Feb-2016 | Later Stage VC | 0000 | Other Healthcare Technology Systems | Generating Revenue/Not Profitable |
Mass General Brigham Innovation Exits (33)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Tarveda Therapeutics | 07-Apr-2022 | Bankruptcy: Liquidation | |
Verve Therapeutics | 17-Jun-2021 | 000 | 00000 |
VisionScope (Diagnostic Equipment) | 01-Feb-2021 | 000000000 00 | |
ProteoThera | 30-Oct-2020 | 000 00 00000 | |
NinePoint Medical | 16-Oct-2020 | 0000000000: | |
Daktari Diagnostics | 20-Apr-2020 | 000 00 00000 | |
Symbiotix Biotherapies | 01-Oct-2019 | 000 00 00000 | |
Health Catalyst | 25-Jul-2019 | 000 | 00000 |
Syntimmune | 02-Nov-2018 | Merger/Acquisition | 00.00 |
Exosome Diagnostics | 01-Aug-2018 | Merger/Acquisition | 00000 |
Mass General Brigham Innovation Investments by Industry, Year, and Region
Mass General Brigham Innovation Management, Team & Partners (72)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Diana Schwartzstein | Managing Director, Administration and Strategy | Cambridge, MA | |||
Michael Band | Business Development Manager | Cambridge, MA | |||
John Flynn | Director International Business Development | Cambridge, MA | |||
Jessica Hanley JD | Director of Contracts | Cambridge, MA | |||
Lesley Watts | Director, Sponsored Programs | Cambridge, MA |
Mass General Brigham Innovation Co-Investors (23)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
RA Capital Management | 2 | 0 | |||
Abingworth | 0 | ||||
Atlas Venture | 0 | 0 | |||
Citadel Enterprise Americas | 0 | ||||
Novo Holdings | 0 |
Mass General Brigham Innovation FAQs
-
What is Mass General Brigham Innovation?
Mass General Brigham Innovation is a corporate venture arm of Mass General Brigham based in Cambridge, Massachusetts.
-
Where is Mass General Brigham Innovation headquartered?
Mass General Brigham Innovation is headquartered in Cambridge, MA.
-
How many investments has Mass General Brigham Innovation made?
Mass General Brigham Innovation has made 47 investments.
-
What has Mass General Brigham Innovation invested in?
Mass General Brigham Innovation has made numerous investments in companies like Verve Therapeutics, Abcuro, and Scorpion Therapeutics within the Drug Discovery industry.
-
What has Mass General Brigham Innovation invested in recently?
Mass General Brigham Innovation's latest investment was on 14-Jan-2021 in Verve Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »